Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients

N/AUnknownNCT02946450

Daewoong Pharmaceutical Co. LTD.3,000 enrolled

Overview

The purpose of this study is to assess safety of Omnipure inj. (lohexol) contrast media in CT scanning patients

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

CT Scanning Patients

Interventions

Other: Not applicable-observational studyDRUG

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * subjects in need of CT scanning * subjects who signed up informed consent Exclusion Criteria: * Known allergy or hypersensitivity to the study medication, ingredient of the medication, and Iodine type medication * severe renal insufficiency patients * severe hypothyroidism * severe local infection or bacteremia

Locations (1)

Asan medical center

Seoul, South Korea

RECRUITING

Outcomes

Primary Outcomes

adverse events, adverse drug reaction, serious adverse events, serious drug reaction, laboratory data, vital signs

Time frame: 14 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.